InvestorsHub Logo

Niceguy1

09/22/21 2:06 PM

#35785 RE: pual #35777

Could also be that what they are doing is simply running the new acquired treatment center which does not require any special notice (8K) ....but that being said...what's required and what is good management practice is far and wide different. Just because you're not required to report something...you should still be communicating with shareholders regularly especially when the PPS has dropped so significantly in the past few months

Bubae

09/22/21 2:30 PM

#35788 RE: pual #35777

The company has already made statements that are not honest, in fact materially deceptive in intent, in the latest two 8Ks and the FAQ page. Due to potential culpability regarding these statements I would seriously doubt they say much else. I would like to know who wrote those 8Ks since they do not represent the true nature of the notes.

Traders here need to put potential revenues in perspective. Ethema appears to me to be simply a financier of operations that were bought into with shareholder dollars. We aren't able to see the balance sheet for ARIA for example so we have no way of determining net earnings from their operations. Any revenue or interest for funds lent that percolates up will likely be minimal in my opinion. According to the 10K Ethema only has 2 employees. Expectations here appear to be out of line with the reality of the liabilities on the balance sheet. You can see their capital burn rate in the quarter over quarter accumulative deficit number. $2.6 million is not good.

10K
https://sec.report/Document/0001721868-21-000220/

Employees

"As of December 31, 2020, Ethema Health Corporation had 2 employees."


https://sec.report/Document/0001721868-21-000524/

Revenues

Revenues were $96,158 and $82,301 for the three months ended June 30, 2021 and 2020, respectively, an increase of $13,857 or 16.8%, this included the rental escalation as per the agreement and a deterioration in the currency exchange rate against the Canadian Dollar over the prior period.


Accumulated deficit June 31 - 47,504,454 and 44,858,784 as of March 31

Bubae

09/22/21 5:45 PM

#35800 RE: pual #35777

OTC information document for filing requirements.

https://www.otcmarkets.com/files/OTCPinkGuidelines.docx

Current Reporting of Material Corporate Events

Companies are expected to release quickly to the public any news or information regarding corporate events that may be material to the issuer and its securities (including adverse information). Persons with knowledge of such events would be considered to be in possession of material nonpublic information and may not buy or sell the issuer’s securities until or unless such information is made public. If not included in the issuer’s previous public disclosure documents or if any of the following events occur after the publication of such disclosure documents, the issuer shall publicly disclose such events by disseminating a news release within 4 business days following their occurrence and posting such news release through an Integrated Newswire or OTCIQ.

Material corporate events include:

> Entry into or termination of a material definitive agreement
> Completion of an acquisition or disposition of assets, including but not limited to merger transactions
> Creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of an issuer
> Triggering events that accelerate or increase a direct financial obligation or an obligation under an off-balance sheet arrangement
> Costs associated with exit or disposal activities
> Material impairments
> Sales of equity securities
> Material modification to rights of security holders
> Changes in issuer's certifying accountant
> Non-reliance on previously issued financial statements or a related audit report or completed interim review
> Changes in control of issuer
> Departure of directors or principal officers; election of directors; appointment of principal officers
> Amendments to articles of incorporation or bylaws; change in fiscal year
> Amendments to the issuer's code of ethics, or waiver of a provision of the code of ethics
> Any changes to litigation the issuer may be involved in, or any new litigation surrounding the issuer
> Officer, director, or insider transactions in the issuer’s securities
> Disclosure regarding stock promotion campaigns deemed material by the issuer
> Changes to the company’s shell status